Ultime notizie per American Vanguard (NYSE:AVD) Azioni

American Vanguard

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard Corp

Avantis International Equity ETF

Avadel Pharmaceuticals plc - Ordinary Share

Avadel Pharmaceuticals PLC

American Century ETF Trust Avantis International Small Cap Equity ETF

Avantis International Small Cap Value ETF

ADVENT AWI HLDGS INC ORD by Advent AWI Hldgs Inc

Advent-AWI Holdings Inc

AvidXchange Holdings, Inc. - Common Stock

AvidXchange Holdings Inc

Product Was Suspended by EPA Based on One Rodent Study
American Vanguard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) today announced that, following its decision in April 2024 to voluntarily stop sales of Dacthal herbicide products, the Company has submitted to the Environmental Protection Agency ("EPA") voluntary cancellation requests for all of its federal registrations of those products. Those registrations are currently the subject of an emergency suspension order that was issued by EPA on August 6, 2024.
In connection with its action, the Company made the following statements.
While the Company continues to question EPA's conclusions in support of the suspension, we believe that the best course of action is to voluntarily cancel registrations of this product. We are working apace with both state and federal authorities to effect product return and to remove Dacthal from channels of distribution. It is the Company's position that product stewardship be international in scope; thus, we will now proceed to voluntarily cancel all international registrations as well.

News

American Vanguard Has Submitted To The EPA Voluntary Cancellation Requests For All Of Its Federal Registrations Of  Dacthal Herbicide Products

WIIM

American Vanguard shares are trading lower after the company reported worse-than-expected Q2 financial results.

Shares of Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) rose sharply in today's pre-market trading reported better-than-expected first-quarter financial results and issued <a href="https://www.benzinga.com/news/earnings/24/08/40269788/doximity-stock-soars-on-q1-earnings-the-details">strong FY24 revenue guidance.</a>
Doximity's first-quarter revenue increased 17% year-over-year to $126.68 million, beating the consensus estimate of $119.92 million, according to Benzinga Pro. The company reported adjusted earnings of 28 cents per share, beating analyst estimates of 22 cents per share.
Doximity shares jumped 28.6% to $33.00 in pre-market trading.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Iteris, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITI#NASDAQ">ITI</a>) rose 61.7% to $6.92 in today's pre-market trading after the company agreed to be acquired by Almaviva for $335 million.</li>
<li>FSD Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUGE#NASDAQ">HUGE</a>) gained 53% to $0.14 in pre-market trading after gaining 16% on Thursday.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) gained 45.8% to $2.80 in pre-market trading. Nauticus Robotics partnered with Florida Atlantic University for cost-effective Aquanaut Mark 2 testing.</li>
<li>Avinger, Inc.. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>) shares rose 28.3% to $1.54 in pre-market trading after reporting second-quarter results.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) gained 27.7% to $10.14 in pre-market trading after the company reported better-than-expected second-quarter financial results and issued Q3 product revenue guidance above estimates.</li>
<li>Clearmind Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) shares gained 27.7% to $1.52 in pre-market trading after declining around 8% on Thursday.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) gained 27.1% to $2.30 in pre-market trading after the company announced AI-powered tool enhancements to its integrations with Reddit and X.</li>
<li>Babcock &amp; Wilcox Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) gained 22.5% to $1.36 following second-quarter results.</li>
<li>Sweetgreen, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) jumped 22.3% to $32.11 in pre-market trading after the company reported better-than-expected second-quarter revenue results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>American Vanguard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) shares dipped 30.8% to $5.66 in pre-market trading after the company reported worse-than-expected second-quarter financial results.</li>
<li>PubMatic, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PUBM#NASDAQ">PUBM</a>) shares declined 26.4% to $14.40 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
<li>Cutera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CUTR#NASDAQ">CUTR</a>) shares declined 21.4% to $0.88 in pre-market trading after the company reported worse-than-expected second-quarter revenue results and cut its FY24 revenue guidance below estimates.</li>
<li>Nerdy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRDY#NYSE">NRDY</a>) declined 20.1% to $1.27 in pre-market trading after the company reported worse-than-expected second-quarter revenue results.</li>
<li>FiscalNote Holdings, Inc.  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOTE#NYSE">NOTE</a>) shares fell 18.3% to $1.12 in pre-market trading after reporting second-quarter results.</li>
<li>Eventbrite, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EB#NYSE">EB</a>) fell 17.1% to $3.15 in today's pre-market trading after the company reported worse-than-expected second-quarter revenue results and issued FY24 revenue guidance below estimates.</li>
<li>AMMO, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWW#NASDAQ">POWW</a>) shares fell 16.7% to $1.35 in pre-market trading after the company reported weak first-quarter sales.</li>
<li>Five9, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVN#NASDAQ">FIVN</a>) fell 16.4% to $35.49 in pre-market trading after the company posted second-quarter results.</li>
<li>Trevena, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) fell 14.7% to $0.19 pre-market trading after the company reported second-quarter results.</li>
<li>Anew Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WENA#NASDAQ">WENA</a>) shares fell 10.1% to $1.15 in pre-market trading after gaining 17% on Thursday.</li>
</ul>
Now Read This: &lt;a href=&#8221;https://www.benzinga.com/news/earnings/24/04/38307448/investor-sentiment-decreases-further-s-p-500-falls-for-fourth-straight-session&#8221;&gt;&lt;em&gt; Investor Sentiment Decreases Further, S&amp;P 500 Falls For Fourth Straight Session&lt;/em&gt;&lt;/a&gt;

Pre-Market Outlook

Markets

Movers

Trading Ideas

AVGR

CMND

CUTR

DOCS

FIVN

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

IOVA

KITT

MRIN

NOTE

NRDY

POWW

PUBM

TRVN

WENA

Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket

American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.01) by 4100 percent. This is a 950 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $128.21 million which missed the analyst consensus estimate of $139.00 million by 7.76 percent. This is a 3.45 percent decrease over sales of $132.79 million the same period last year.

Earnings

Earnings Misses

American Vanguard Q2 EPS $(0.42) Misses $(0.01) Estimate, Sales $128.21M Miss $139.00M Estimate

Lake Street analyst Ben Klieve initiates coverage on American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) with a Buy rating and announces Price Target of $14.

Price Target

Initiation

Analyst Ratings

Lake Street Initiates Coverage On American Vanguard with Buy Rating, Announces Price Target of $14

Management

American Vanguard Reports CEO Eric G. Wintemute Steps Down, Effective July 12, 2024; Will Continue As Chairman And Provide Consulting Services Part-Time Per Transition Agreement Dated July 3, 2024

American Vanguard Chairman And CEO Eric Wintemute To Retire As CEO

American Vanguard Executive Vice President & COO Bob Trogele To Retire, Effective May 31, 2024

American Vanguard shares are trading lower after the company reported worse-than-expected Q1 financial results.

Shares of Diodes Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DIOD#NASDAQ">DIOD</a>) fell sharply during Friday's session after the company reported worse-than-expected <a href="https://www.benzinga.com/quote/DIOD/earnings">quarterly financial results</a>.
Diodes posted adjusted earnings of 28 cents per share, missing market estimates of 31 cents per share. The company's quarterly sales came in at $301.97 million missing expectations of $305.01 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Diodes shares dipped 9.8% to $68.99 on Friday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Novavax, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVAX#NASDAQ">NVAX</a>) shares jumped 139% to $10.73 after the company and Sanofi announced a co-exclusive licensing agreement to commercialize a COVID-19 vaccine and develop COVID-influenza combination vaccines.</li>
<li>iTeos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) gained 40% to $17.06 after the company announced a $120 million registered direct offering and reported Q1 financial results.</li>
<li>AEye, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) shares climbed 39.8% to $1.65 after the company disclosed a partnership with LITEON Technology Corporation.</li>
<li>Sweetgreen, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) shares climbed 39.4% to $32.86 after the company reported better-than-expected first-quarter sales results.</li>
<li>Ouster, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) gained 34.3% to $13.90 after the company reported better-than-expected first-quarter financial results.</li>
<li>Organogenesis Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>) rose 32% to $3.02 following upbeat quarterly results.</li>
<li>Inseego Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSG#NASDAQ">INSG</a>) gained 31.4% to $5.05 after the company reported better-than-expected first-quarter financial results and issued second-quarter revenue guidance above estimates.</li>
<li>CareDx, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) surged 26.3% to $13.99 after the company reported better-than-expected first-quarter financial results and issued FY24 revenue guidance above estimates.</li>
<li>Sensus Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) shares rose 22.5% to $4.6699 after the company reported better-than-expected first-quarter financial results.</li>
<li>Groupon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) gained 22.3% to $12.85 after the company reported better-than-expected first-quarter results.</li>
<li>Standard Lithium Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLI#NYSE">SLI</a>) jumped 21.8% to $1.90 after the company reported better-than-expected quarterly GAAP EPS results.</li>
<li>ADMA Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) rose 21% to $8.39 after the company reported better-than-expected first-quarter financial results and issued strong revenue guidance.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) shares gained 19.3% to $5.66 in pre-market trading after the company reported better-than-expected first quarter financial results.</li>
<li>American Coastal Insurance Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACIC#NASDAQ">ACIC</a>) rose 17.2% to $12.79 after the company reported better-than-expected first quarter financial results. The company announced the sale of 100% of its issued and outstanding stock of Interboro Insurance Company to Forza Insurance Holdings.</li>
<li>Global Gas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGAS#NASDAQ">HGAS</a>) rose 15.3% to $1.28.</li>
<li>Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) gained 15% to $23.42 after the company reported better-than-expected quarterly earnings and authorized a $3 billion share repurchase program.</li>
<li>Mettler-Toledo International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTD#NYSE">MTD</a>) gained 14.6% to $1,478.49 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) rose 14.4% to $7.61.</li>
<li>Clean Energy Fuels Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) climbed 13.6% to $2.74 following upbeat quarterly results.</li>
<li>Natural Grocers by Vitamin Cottage, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGVC#NASDAQ">NGVC</a>) gained 13.2% to $20.19 following second-quarter results.</li>
<li>Natera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NASDAQ">NTRA</a>) rose 11.3% to $106.36 following strong first-quarter earnings.</li>
<li>NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) jumped 11% to $6.50 following first-quarter results.</li>
<li>Integral Ad Science Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IAS#NASDAQ">IAS</a>) gained 8.8% to $9.12 after the company reported better-than-expected first-quarter sales results and issued FY24 revenue guidance above estimates.</li>
<li>Dutch Bros Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BROS#NYSE">BROS</a>) jumped 8.7% to $35.68 after TD Cowen upgraded the stock from Hold to Buy and raised its price target from $33 to $46.</li>
<li>Funko Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) gained 7% to $7.30 as the company reported better-than-expected first-quarter earnings and issued strong earnings forecast for the second quarter. The company also appointed Cynthia Williams as its Chief Executive Officer, effective May 20.</li>
<li>Genpact Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/G#NYSE">G</a>) gained 6.8% to $34.26 after the company reported better-than-expected first-quarter financial results and raised its FY24 EPS range.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) shares rose 3.5% to $12.94 after the company reported stronger-than-expected financial results for the first quarter on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>MacroGenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNX#NASDAQ">MGNX</a>) shares fell 73.4% to $3.9089 after the company reported worse-than-expected first-quarter financial results.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) fell 37.2% to $0.0439 after jumping 20% on Thursday.</li>
<li>Flux Power Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLUX#NASDAQ">FLUX</a>) dipped 35.8% to $2.9350 after the company reported worse-than-expected quarterly financial results.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) fell 29.3% to $1.30 after the company announced second half and full year 2023 financial results.</li>
<li>Evolv Technologies Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVLV#NASDAQ">EVLV</a>) fell 29.2% to $2.7290 after the company reported worse-than-expected first-quarter financial results and lowered its FY24 sales guidance below estimates.</li>
<li>Revance Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVNC#NASDAQ">RVNC</a>) fell 27% to $3.0950 as the company posted a loss for its first quarter on Thursday.</li>
<li>Biofrontera Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFRI#NASDAQ">BFRI</a>) fell 26.6% to $1.16.</li>
<li>American Vanguard Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) dipped 22.2% to $9.84 following weak quarterly results.</li>
<li>UTime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) dipped 22% to $0.25.</li>
<li>The Beauty Health Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKIN#NASDAQ">SKIN</a>) fell 22% to $2.80 following quarterly results.</li>
<li>MicroVision, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) shares fell 21.6% to $1.27 after the company reported worse-than-expected first-quarter GAAP EPS results.</li>
<li>Progyny, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PGNY#NASDAQ">PGNY</a>) shares fell 21.5% to $25.51 after the company reported worse-than-expected first-quarter sales results and issued FY24 sales guidance below estimates.</li>
<li>Pineapple Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) shares declined 20.7% to $0.0579 after the company reported worse-than-expected first quarter financial results.</li>
<li>The E.W. Scripps Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSP#NASDAQ">SSP</a>) dipped 19.7% to $3.71 following quarterly results.</li>
<li>CS Disco, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAW#NYSE">LAW</a>) fell 19.6% to $6.50 following weak sales.</li>
<li>Safe and Green Development Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGD#NASDAQ">SGD</a>) shares fell 18.4% to $0.6937 after jumping around 37% on Thursday.</li>
<li>Docebo Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCBO#NASDAQ">DCBO</a>) fell 18.2% to $37.99.</li>
<li>JFrog Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FROG#NASDAQ">FROG</a>) shares fell 17.7% to $33.43 after the company reported first quarter financial results.</li>
<li>Ginkgo Bioworks Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>) shares fell 17.3% to $0.7606 after the company reported worse-than-expected first-quarter sales results.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IOVA#NASDAQ">IOVA</a>) fell 15.6% to $11.35 following first-quarter financial results.</li>
<li>Gritstone bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRTS#NASDAQ">GRTS</a>) shares declined 14.4% to $0.8320 after the company reported worse-than-expected first quarter GAAP EPS results.</li>
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) shares fell 12.8% to $4.0850 after the company reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Forward Air Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) declined 12.2% to $14.72.</li>
<li>Arrowhead Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARWR#NASDAQ">ARWR</a>) fell 11.1% to $21.97 after the company reported second-quarter financial results.</li>
<li>AMN Healthcare Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMN#NYSE">AMN</a>) fell 9.5% to $55.08 following first-quarter results.</li>
<li>Evolent Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) fell 8.4% to $24.69 after the company reported first-quarter financial results.</li>
<li>Akamai Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAM#NASDAQ">AKAM</a>) fell 8.1% to $94.16 after the company issued weak guidance.</li>
<li>Fluence Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLNC#NASDAQ">FLNC</a>) declined 7.8% to $17.28 following second-quarter financial results.</li>
<li>Aurora Innovation, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUR#NASDAQ">AUR</a>) dipped 7.4% to $3.3399.</li>
<li>MoonLake Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) fell 7% to $39.02.</li>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) fell 5% to $33.13. BMO Capital analyst James Fotheringham maintained Affirm with a Market Perform and lowered the price target from $48 to $46.</li>
<li>Runway Growth Finance Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RWAY#NASDAQ">RWAY</a>) shares fell 4.1% to $11.61 as the company priced its secondary offering of 3.75 million common stock by selling stockholder at $11.50 per share.</li>
<li>Yelp Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YELP#NYSE">YELP</a>) shares declined 3.6% to $38.20 after the company reported a first-quarter revenue miss.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38760794/bitcoin-tops-63-000-akash-network-emerges-as-top-gainer">Bitcoin Tops $63,000; Akash Network Emerges As Top Gainer</a>

Intraday Update

ACIC

ADMA

AEHL

AFRM

AKAM

ARRY

ARWR

BFRI

BROS

CDNA

CLNE

DCBO

DIOD

EVLV

FLNC

FLUX

FNKO

FROG

FWRD

GRPN

GRTS

GWAV

HGAS

INSG

ITOS

LIDR

MGNX

MLTX

MVIS

NGVC

NTRA

NVAX

NVTS

ORGO

OUST

PEGY

PGNY

RVNC

RWAY

SKIN

SKYT

SOUN

SRTS

YELP

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.12 by 50 percent. The company reported quarterly sales of $135.00 million which missed the analyst consensus estimate of $141.90 million by 4.86 percent. This is a 8.10 percent increase over sales of $124.89 million the same period last year.

American Vanguard Q1 2024 GAAP EPS $0.06 Misses $0.12 Estimate, Sales $135.00M Miss $141.90M Estimate

Valvoline (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vvv#NYSE">VVV</a>) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.23 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 2.78%. A quarter ago, it was expected that this automotive and industrial lubricants maker would post earnings of $0.29 per share when it actually produced earnings of $0.29, delivering no surprise.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Valvoline, which belongs to the Zacks Chemical - Specialty industry, posted revenues of $388.7 million for the quarter ended March 2024, surpassing the Zacks Consensus Estimate by 0.05%. This compares to year-ago revenues of $344.5 million. The company has topped consensus revenue estimates two times over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Valvoline shares have added about 17.6% since the beginning of the year versus the S&amp;P 500&#39;s gain of 8.8%.
What&#39;s Next for Valvoline?
While Valvoline has outperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Valvoline: favorable. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.49 on $422.34 million in revenues for the coming quarter and $1.61 on $1.62 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the top 31% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, American Vanguard (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avd#NYSE">AVD</a>), is yet to report results for the quarter ended March 2024.
This agricultural products company is expected to post quarterly earnings of $0.08 per share in its upcoming report, which represents a year-over-year change of +14.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
American Vanguard&#39;s revenues are expected to be $141.2 million, up 13.1% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2270287/valvoline-vvv-surpasses-q2-earnings-and-revenue-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2270287">To read this article on Zacks.com click here.</a>

Earnings Beats

Small Cap

Valvoline Surpasses Q2 Earnings and Revenue Estimates

Loop Capital analyst Chris Kapsch maintains American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) with a Buy and raises the price target from $19 to $20.

Loop Capital Maintains Buy on American Vanguard, Raises Price Target to $20

Financial Advisors

Penny Stocks

Personal Finance

ATRO

MATV

QUAD

SNCR

5 Top Small Cap Stocks with Growth and Value

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday.
The Dow traded down 0.55% to 38,692.43 while the NASDAQ fell 0.90% to 15,982.65. The S&amp;P 500 also fell, dropping, 0.64% to 5,117.35.
Check This Out: <a href="https://www.benzinga.com/news/24/03/37744144/top-5-industrials-stocks-that-may-fall-off-a-cliff-in-q1"> Top 5 Industrials Stocks That May Fall Off A Cliff In Q1</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Materials shares jumped by 0.2% on Friday.
In trading on Friday, information technology shares fell by 1.4%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
Shares of Adobe Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>) fell around 14% on Friday after the company issued a weak forecast.
Adobe reported better-than-expected results for its first quarter but issued weak revenue guidance for the current quarter. The company said it sees second-quarter revenue in the range of $5.25 billion to $5.30 billion versus estimates of $5.31 billion, according to data from Benzinga Pro.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Verb Technology Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verb#NASDAQ">VERB</a>) shares shot up 219% to $0.4461. VERB&#39;s MARKET.live launched Facebook and Instagram social shopping technology integration.
Shares of Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) got a boost, surging 64% to $13.45 after the company reported better-than-expected fourth-quarter earnings.
American Vanguard Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avd#NYSE">AVD</a>) shares were also up, gaining 22% to $12.91 following fourth-quarter financial results.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares dropped 62% to $0.0297 after the company announced pricing of a $6 million underwritten public offering.
Shares of SELLAS Life Sciences Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sls#NASDAQ">SLS</a>) were down 29% to $1.1050. SELLAS Life Sciences Group announced a $20 million registered direct offering and concurrent private placement of 13,029316 shares each for combined purchase price of $1.535/share.
Immuneering Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrx#NASDAQ">IMRX</a>) was down, falling 29% to $2.0450 after multiple analysts downgraded the stock following Thursday data from the company&#39;s Phase 1 portion of its Phase 1/2a clinical trial of IMM-1-104 in advanced RAS-mutant solid tumors.
Also Check This Out:<a href="https://www.benzinga.com/news/24/03/37744366/wall-streets-most-accurate-analysts-say-hold-these-3-tech-stocks-delivering-high-dividend-yields"> Wall Street&#39;s Most Accurate Analysts Say Hold These 3 Tech Stocks Delivering High-Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.2% to $81.12 while gold traded down 0.3% at $2,162.00.
Silver traded up 1.5% to $25.435 on Friday, while copper rose 1.9% to $4.1205.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares closed mixed today. The eurozone&rsquo;s STOXX 600 slipped 0.32%, London&rsquo;s FTSE 100 fell 0.20% while Spain&rsquo;s IBEX 35 Index rose 1.02% The German DAX fell 0.03% French CAC 40 rose 0.04% while Italy&rsquo;s FTSE MIB Index gained 0.46%.
The annual inflation rate in Italy was confirmed at 0.8% in February, while annual inflation rate in France fell to 3% in February from 3.1% a month ago.
&nbsp;
<h3>Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Friday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index falling 1.42%, China&rsquo;s Shanghai Composite Index gaining 0.54% and India&rsquo;s S&amp;P BSE Sensex dipping 0.7%.
China&#39;s new home prices fell by 1.4% year-over-year in February, while the People&#39;s Bank of China held the interest rate at 2.50%. The unemployment rate for Singapore was confirmed at 2.0% for the fourth quarter.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. manufacturing production increased by 0.8% month-over-month in February.
U.S. industrial production rose by 0.1% from the prior month in February.
The NY Empire State Manufacturing Index fell to -20.9 in March versus -2.4 in February.
Export prices in the U.S. increased 0.8% month-over-month in February, while import prices rose by 0.3%.
The University of Michigan consumer sentiment fell to 76.5 in March, recording the lowest reading in three months, compared to 76.9 in February.
The total number of active U.S. oil rigs climbed by 6 rigs this week, Baker Hughes Inc reported.
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37725132/how-to-earn-500-a-month-from-dollar-general-stock-following-earnings-beat"> How To Earn $500 A Month From Dollar General Stock Following Earnings Beat </a>

Eurozone

Commodities

Global

ADBE

CDLX

CISS

IMRX

VERB

Dow Falls Over 200 Points; Adobe Shares Plunge

Shares of Jabil Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jbl#NYSE">JBL</a>) fell sharply during Friday&rsquo;s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.
Jabil posted adjusted earnings of $1.68 per share, beating estimates of $1.66 per share. The company&rsquo;s quarterly sales came in at $6.77 billion, missing expectations of $6.89 billion.
Jabil shares dipped 14.2% to $126.56 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Verb Technology Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verb#NASDAQ">VERB</a>) shares jumped 189% to $0.4047. VERB&#39;s MARKET.live launched Facebook and Instagram social shopping technology integration.</li>
<li>Better Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bttx#NASDAQ">BTTX</a>) surged 108% to $0.0728. Better Therapeutics recently said it will seek strategic alternatives and will be delisted from the Nasdaq.</li>
<li>Jet.AI Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jtai#NASDAQ">JTAI</a>) shares climbed 76.7% to $1.1950.</li>
<li>Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) rose 57.1% to $12.86 after the company reported better-than-expected fourth-quarter earnings.</li>
<li>American Vanguard Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avd#NYSE">AVD</a>) climbed 25.8% to $13.32 following fourth-quarter financial results.</li>
<li>Blend Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blnd#NASDAQ">BLND</a>) climbed 24.3% to $2.92 after the company reported fourth-quarter financial results.</li>
<li>HCM Acquisition Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcma#NASDAQ">HCMA</a>) gained 22.8% to $12.00.</li>
<li>Solidion Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sti#NASDAQ">STI</a>) rose 22.2% to $1.5897. The company announced the pricing of a $3.85 million private placement.</li>
<li>Tredegar Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tg#NYSE">TG</a>) surged 18% to $4.73 following fourth-quarter financial results.</li>
<li>BranchOut Food Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bof#NASDAQ">BOF</a>) rose 17.3% to $2.20. BranchOut Food will debut new products at Natural Products Expo West.</li>
<li>Madrigal Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdgl#NASDAQ">MDGL</a>) rose 16.3% to $283.29 after the company announced FDA approval of Rezdiffra for the treatment of patients with noncirrhotic NASH with moderate to advanced liver fibrosis.</li>
<li>Secoo Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/seco#NASDAQ">SECO</a>) gained 16% to $0.5017.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) jumped 15.1% to $31.81. Roth MKM recently maintained a Buy rating on the stock and raised its price target from $12.50 to $27.50.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) jumped 14.3% to $15.56 after the company reported financial fourth-quarter results above estimates and issued first-quarter revenue guidance.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) gained 13% to $2.11.</li>
<li>CommScope Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/comm#NASDAQ">COMM</a>) rose 13% to $1.6502.</li>
<li>CS Disco, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/law#NYSE">LAW</a>) surged 11.9% to $7.71. CS Disco&rsquo;s board approved a $20 million share repurchase authorization.</li>
<li>Alta Equipment Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/altg#NYSE">ALTG</a>) rose 10.7% to $11.64 following better-than-expected fourth-quarter 2023 results.</li>
<li>Despegar.com, Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/desp#NYSE">DESP</a>) gained 9.6% to $10.85 after the company reported mixed fourth-quarter 2023 results, with sales beating estimates.</li>
<li>Aquestive Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aqst#NASDAQ">AQST</a>) shares gained 7.2% to $5.63. Aquestive Therapeutics said Anaphylm met all predefined primary and secondary pharmacokinetic endpoints.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) shares rose 6.7% to $0.1654. Fisker shares dipped around 52% on Thursday following a Wall Street Journal report suggesting the company is preparing for a possible bankruptcy filing.</li>
<li>The Buckle, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bke#NYSE">BKE</a>) gained 5.4% to $39.71 following fourth-quarter 2023 results.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares fell 62.5% to $0.0296 after the company announced pricing of a $6 million underwritten public offering.</li>
<li>SELLAS Life Sciences Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sls#NASDAQ">SLS</a>) fell 34.8% to $1.01. SELLAS Life Sciences Group announced a $20 million registered direct offering and concurrent private placement of 13,029316 shares each for combined purchase price of $1.535/share.</li>
<li>Immuneering Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrx#NASDAQ">IMRX</a>) dipped 27% to $2.1150 after multiple analysts downgraded the stock following Thursday data from the company&#39;s Phase 1 portion of its Phase 1/2a clinical trial of IMM-1-104 in advanced RAS-mutant solid tumors.</li>
<li>Lucy Scientific Discovery Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lsdi#NASDAQ">LSDI</a>) fell 25.6% to $1.25.</li>
<li>Xcel Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xelb#NASDAQ">XELB</a>) dipped 22.1% to $0.7630 after the company announced pricing of a $2.42 million public offering of common stock and concurrent private placement.</li>
<li>Altus Power, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amps#NYSE">AMPS</a>) declined 19.7% to $4.7650 after the company reported worse-than-expected quarterly financial results and issued FY24 revenue guidance below estimates.</li>
<li>Presto Automation Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prst#NASDAQ">PRST</a>) fell 19.1% to $0.2438 after surging 34% on Thursday. The company announced the pricing of a $1.2 million registered direct offering of 4.8 million shares of common stock at $0.25 per share.</li>
<li>Babcock &amp; Wilcox Enterprises, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bw#NYSE">BW</a>) dipped 19.1% to $1.0350 after the company reported worse-than-expected quarterly financial results.</li>
<li>Biofrontera Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfri#NASDAQ">BFRI</a>) declined 18.3% to $1.43.</li>
<li>Groupon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grpn#NASDAQ">GRPN</a>) fell 17.8% to $14.91 after the company reported fourth-quarter financial results.</li>
<li>EverCommerce Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/evcm#NASDAQ">EVCM</a>) fell 17.3% to $7.74 following weak quarterly results.</li>
<li>Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) fell 14.3% to $1.3627. Psyence Biomedical shares jumped 53% on Thursday after the Indiana legislature sent a bill that includes funding for psilocybin clinical research trials to the governor.</li>
<li>Adobe Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>) dipped 13.3% to $494.25. Adobe reported better-than-expected results for its first quarter but issued weak revenue guidance for the current quarter.</li>
<li>Blink Charging Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blnk#NASDAQ">BLNK</a>) shares fell 11.8% to $3.0250 following fourth-quarter financial results.</li>
<li>Montauk Renewables, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mntk#NASDAQ">MNTK</a>) tumbled 10.8% to $4.54 following weak quarterly results.</li>
<li>Kopin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kopn#NASDAQ">KOPN</a>) fell 10.3% to $1.9650 after reporting weaker-than-expected fourth-quarter results.</li>
<li>AdTheorent Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adth#NASDAQ">ADTH</a>) dipped 10% to $3.35.</li>
<li>PagerDuty, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pd#NYSE">PD</a>) shares fell 9.7% to $20.70 after the company reported fourth-quarter financial results and issued FY25 guidance below estimates.</li>
<li>Soho House &amp; Co Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shco#NYSE">SHCO</a>) declined 9.7% to $5.19 following downbeat fourth-quarter financial results.</li>
<li>Zillow Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/z#NASDAQ">Z</a>) dipped 8.3% to $50.55.</li>
<li>Ulta Beauty, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ulta#NASDAQ">ULTA</a>) shares tumbled 6.5% to $528.96 after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates. The company&#39;s board of directors approved a new share repurchase authorization of $2.0 billion.</li>
<li>Sanmina Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sanm#NASDAQ">SANM</a>) dipped 5.8% to $59.45.</li>
<li>Smartsheet Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smar#NASDAQ">SMAR</a>) fell 4.3% to $38.57 after the company reported fourth-quarter financial results and issued FY25 revenue guidance below estimates.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) shares fell 3% to $1,627.26. MicroStrategy shares fell 5% on Thursday after the company announced a proposed private offering of $500 million of convertible senior notes due 2031.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/24/03/37745952/ethereum-falls-below-3-700-bitcoin-sv-injective-among-top-losers"> Ethereum Falls Below $3,700; Bitcoin SV, Injective Among Top Losers </a>

ADTH

ALTG

AMPS

AQST

BLND

BLNK

BTTX

COMM

DESP

DRCT

EVCM

HCMA

JTAI

KOPN

LSDI

MDGL

MNTK

MSTR

PRST

SANM

SECO

SHCO

SMAR

ULTA

XELB

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 100 points on Friday.
The Dow traded down 0.37% to 38,761.74 while the NASDAQ fell 0.95% to 15,974.83. The S&amp;P 500 also fell, dropping, 0.62% to 5,118.35.
Check This Out: <a href="https://www.benzinga.com/news/24/03/37744144/top-5-industrials-stocks-that-may-fall-off-a-cliff-in-q1"> Top 5 Industrials Stocks That May Fall Off A Cliff In Q1</a>
&nbsp;
<h3>Leading and Lagging Sectors</h3>
&nbsp;
Energy shares jumped by 0.6% on Friday.
In trading on Friday, information technology shares fell by 0.9%.
&nbsp;
<h3>Top Headline</h3>
&nbsp;
The University of Michigan consumer sentiment fell to 76.5 in March, recording the lowest reading in three months, compared to 76.9 in February.
&nbsp;
<h3>Equities Trading UP</h3>
&nbsp;
Verb Technology Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verb#NASDAQ">VERB</a>) shares shot up 202% to $0.4221. VERB&#39;s MARKET.live launched Facebook and Instagram social shopping technology integration.
Shares of Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) got a boost, surging 54% to $12.59 after the company reported better-than-expected fourth-quarter earnings.
American Vanguard Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avd#NYSE">AVD</a>) shares were also up, gaining 24% to $13.11 following fourth-quarter financial results.
&nbsp;
<h3>Equities Trading DOWN</h3>
&nbsp;
C3is Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciss#NASDAQ">CISS</a>) shares dropped 65% to $0.0280 after the company announced pricing of a $6 million underwritten public offering.
Shares of SELLAS Life Sciences Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sls#NASDAQ">SLS</a>) were down 32% to $1.06. SELLAS Life Sciences Group announced a $20 million registered direct offering and concurrent private placement of 13,029316 shares each for combined purchase price of $1.535/share.
Immuneering Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrx#NASDAQ">IMRX</a>) was down, falling 24% to $2.2097 after multiple analysts downgraded the stock following Thursday data from the company&#39;s Phase 1 portion of its Phase 1/2a clinical trial of IMM-1-104 in advanced RAS-mutant solid tumors.
Also Check This Out:<a href="https://www.benzinga.com/news/24/03/37744366/wall-streets-most-accurate-analysts-say-hold-these-3-tech-stocks-delivering-high-dividend-yields"> Wall Street&#39;s Most Accurate Analysts Say Hold These 3 Tech Stocks Delivering High-Dividend Yields </a>
&nbsp;
<h3>Commodities</h3>
&nbsp;
In commodity news, oil traded down 0.6% to $80.78 while gold traded down 0.1% at $2,165.70.
Silver traded up 2.2% to $25.615 on Friday, while copper rose 1.6% to $4.1105.
&nbsp;
<h3>Euro zone</h3>
&nbsp;
European shares were mostly higher today. The eurozone&rsquo;s STOXX 600 slipped 0.02%, London&rsquo;s FTSE 100 rose 0.29% while Spain&rsquo;s IBEX 35 Index rose 1.26% The German DAX gained 0.24% French CAC 40 rose 0.43% while Italy&rsquo;s FTSE MIB Index gained 0.44%.
The annual inflation rate in Italy was confirmed at 0.8% in February, while annual inflation rate in France fell to 3% in February from 3.1% a month ago.
<h3>
Asia Pacific Markets</h3>
&nbsp;
Asian markets closed mostly lower on Friday, with Japan&rsquo;s Nikkei 225 falling 0.26%, Hong Kong&rsquo;s Hang Seng Index falling 1.42%, China&rsquo;s Shanghai Composite Index gaining 0.54% and India&rsquo;s S&amp;P BSE Sensex dipping 0.7%.
China&#39;s new home prices fell by 1.4% year-over-year in February, while the People&#39;s Bank of China held the interest rate at 2.50%. The unemployment rate for Singapore was confirmed at 2.0% for the fourth quarter.
&nbsp;
<h3>Economics</h3>
&nbsp;
U.S. manufacturing production increased by 0.8% month-over-month in February.
U.S. industrial production rose by 0.1% from the prior month in February.
The NY Empire State Manufacturing Index fell to -20.9 in March versus -2.4 in February.
Export prices in the U.S. increased 0.8% month-over-month in February, while import prices rose by 0.3%.
The University of Michigan consumer sentiment fell to 76.5 in March, recording the lowest reading in three months, compared to 76.9 in February.
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37725132/how-to-earn-500-a-month-from-dollar-general-stock-following-earnings-beat"> How To Earn $500 A Month From Dollar General Stock Following Earnings Beat </a>

Crude Oil Edges Lower; US Consumer Sentiment Falls In March

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday.
Shares of Blend Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blnd#NASDAQ">BLND</a>) rose sharply during Friday&rsquo;s session after the company reported <a href="https://www.benzinga.com/quote/BLND/earnings">fourth-quarter financial results.</a>
Blend Labs posted quarterly loss of 9 cents per share, in-line with market estimates of 9 cents per share. The company&rsquo;s quarterly sales came in at $36.10 million versus estimates of $36.93 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Blend Labs shares jumped 24.3% to $2.92 on Friday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Cardlytics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) jumped 57.1% to $12.86 after the company reported better-than-expected fourth-quarter earnings.</li>
<li>American Vanguard Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avd#NYSE">AVD</a>) rose 25.8% to $13.32 following fourth-quarter financial results.</li>
<li>Tredegar Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tg#NYSE">TG</a>) climbed 18% to $4.73 following fourth-quarter financial results.</li>
<li>Madrigal Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdgl#NASDAQ">MDGL</a>) gained 16.3% to $283.29 after the company announced FDA approval of Rezdiffra for the treatment of patients with noncirrhotic NASH with moderate to advanced liver fibrosis.</li>
<li>Direct Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drct#NASDAQ">DRCT</a>) climbed 15.1% to $31.81. Roth MKM recently maintained a Buy rating on the stock and raised its price target from $12.50 to $27.50.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) rose 14.3% to $15.56 after the company reported financial fourth-quarter results above estimates and issued first-quarter revenue guidance.</li>
<li>CommScope Holding Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/comm#NASDAQ">COMM</a>) surged 13% to $1.6502.</li>
<li>CARGO Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crgx#NASDAQ">CRGX</a>) gained 13% to $31.74.</li>
<li>CS Disco, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/law#NYSE">LAW</a>) rose 11.9% to $7.71. CS Disco&rsquo;s board approved a $20 million share repurchase authorization.</li>
<li>Alta Equipment Group Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/altg#NYSE">ALTG</a>) gained 10.7% to $11.64 following better-than-expected fourth-quarter 2023 results.</li>
<li>Despegar.com, Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/desp#NYSE">DESP</a>) climbed 9.6% to $10.85 after the company reported mixed fourth-quarter 2023 results, with sales beating estimates.</li>
<li>Bitdeer Technologies Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/btdr#NASDAQ">BTDR</a>) gained 8.8% to $7.03.</li>
<li>Tenaya Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tnya#NASDAQ">TNYA</a>) rose 8.6% to $5.18.</li>
<li>Archer Aviation Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/achr#NYSE">ACHR</a>) gained 7.4% to $5.25.</li>
<li>Bioventus Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bvs#NASDAQ">BVS</a>) gained 6.9% to $5.55.</li>
<li>Solid Biosciences Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sldb#NASDAQ">SLDB</a>) gained 6.9% to $13.13. Piper Sandler recently upgraded the stock from Neutral to Overweight and raised its price target from $8 to $20.</li>
<li>Lithium Americas Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lac#NYSE">LAC</a>) gained 6% to $6.35 following 2023 full year and fourth quarter results.</li>
<li>The Buckle, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bke#NYSE">BKE</a>) rose 5.4% to $39.71 following fourth-quarter 2023 results.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/03/37725132/how-to-earn-500-a-month-from-dollar-general-stock-following-earnings-beat"> How To Earn $500 A Month From Dollar General Stock Following Earnings Beat</a>

ACHR

BTDR

CRGX

SLDB

TNYA

Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday

Roth MKM analyst Scott Fortune maintains American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) with a Buy and raises the price target from $13 to $16.

Roth MKM Maintains Buy on American Vanguard, Raises Price Target to $16

American Vanguard shares are trading higher. The company reported Q4 financial results.

American Vanguard: Panic Selloff Makes Shares Attractive

In a report released today, Ben Klieve from Lake Street assigned a Buy rating to American Vanguard (AVD – Research Report), with a price target of ...

American Vanguard (AVD) Receives a Buy from Lake Street

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
American Vanguard (NYSE:<a href="https://investorplace.com/stock-quotes/avd-stock-quote/">AVD</a>) just reported results for the second quarter of 2024.<ul><li>American Vanguard reported earnings per share of -42 cents. This was below the analyst estimate for EPS of -1 cent.</li><li>The company reported revenue of $128.21 million.</li><li>This was 7.76% worse than the analyst estimate for revenue of $139.00 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/avd-stock-earnings-american-vanguard-for-q2-of-2024/">AVD Stock Earnings: American Vanguard Misses EPS, Misses Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

AVD Stock Earnings: American Vanguard Misses EPS, Misses Revenue for Q2 2024

American Vanguard misses top-line and bottom-line estimates; lowers FY24 outlook

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have all of the biggest pre-market stock movers that traders need to know about on Friday morning!



Moving stocks this morning and more earnings reports, an acquisition deal, liquidation news and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Iteris (NASDAQ:<a href="https://investorplace.com/stock-quotes/iti-stock-quote/">ITI</a>) stock is rocketing more than 62% <a href="https://www.nasdaq.com/press-release/iteris-be-acquired-almaviva-335-million-2024-08-09">alongside an acquisition deal</a>.</li>



<li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) shares are soaring over 61% on a <a href="https://www.nasdaq.com/press-release/nauticus-robotics-enters-aquanaut-mark-2-testing-partnership-fau-2024-08-08">new testing partnership</a>.</li>



<li>FSD Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/huge-stock-quote/">HUGE</a>) stock is surging more than 37% alongside heavy pre-market trading.</li>



<li>Bone Biologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bblg-stock-quote/">BBLG</a>) shares are gaining over 30% with the <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318504957&amp;type=PDF&amp;symbol=BBLG&amp;cdn=81b72413280ee9face7494c21cc37055&amp;companyName=Bone+Biologics+Corp&amp;formType=ARS&amp;formDescription=Annual+Report+to+Security+Holders&amp;dateFiled=2024-08-08">release of its annual report</a>.</li>



<li>Pitney Bowes (NYSE:<a href="https://investorplace.com/stock-quotes/pbi-stock-quote/">PBI</a>) stock is rising more than 30% on plans to <a href="https://finance.yahoo.com/news/pitney-bowes-liquidate-ecommerce-unit-221312483.html">liquidate its e-commerce unit</a>.</li>



<li>Marin Software (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrin-stock-quote/">MRIN</a>) shares are increasing over 28% after <a href="https://www.businesswire.com/news/home/20240808458407/en/Marin-Software-Extends-Reach-with-Reddit-and-X-Support">adding support for Reddit and X</a>, previously called Twitter.</li>



<li>Clearmind Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmnd-stock-quote/">CMND</a>) stock is heading more than 27% higher without any clear news this morning.</li>



<li>Doximity (NYSE:<a href="https://investorplace.com/stock-quotes/docs-stock-quote/">DOCS</a>) shares are climbing over 27% on a <a href="https://www.marketwatch.com/story/doximity-shares-rally-after-beating-1q-earnings-guidance-expectations-b9ce97d7?mod=markets">fiscal Q1 earnings beat</a>.</li>



<li>Satellogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/satl-stock-quote/">SATL</a>) stock is jumping more than 26% today.</li>



<li>Babcock &amp; Wilcox (NYSE:<a href="https://investorplace.com/stock-quotes/bw-stock-quote/">BW</a>) shares are up over 25% after releasing its <a href="https://www.businesswire.com/news/home/20240808728017/en/Babcock-Wilcox-Enterprises-Reports-Second-Quarter-2024-Results-Earnings-Growth-Driven-By-Strong-Operating-Performance">Q2 earnings report</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>AN2 Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/antx-stock-quote/">ANTX</a>) stock is diving more than 33% <a href="https://www.nasdaq.com/press-release/an2-therapeutics-provides-update-ebo-301-phase-2-3-study-evaluating-epetraborole">with a clinical trial update</a>.</li>



<li>American Vanguard (NYSE:<a href="https://investorplace.com/stock-quotes/avd-stock-quote/">AVD</a>) shares are tumbling over 29% with the <a href="https://www.nasdaq.com/press-release/american-vanguard-reports-q2-2024-results-2024-08-08">release of its latest earnings report</a>.</li>



<li>PubMatic (NASDAQ:<a href="https://investorplace.com/stock-quotes/pubm-stock-quote/">PUBM</a>) stock is taking a more than 27% beating on <a href="https://www.stocktitan.net/news/PUBM/pub-matic-announces-second-quarter-2024-financial-zmrbbq0dmfh8.html">missed Q2 revenue</a>.</li>



<li>Eventbrite (NYSE:<a href="https://investorplace.com/stock-quotes/eb-stock-quote/">EB</a>) shares are sliding over 23% alongside <a href="https://www.tipranks.com/news/company-announcements/eventbrite-announces-layoffs-and-welcomes-new-coo-cfo">layoffs and leadership changes</a>.</li>



<li>Beauty Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/skin-stock-quote/">SKIN</a>) stock is decreasing more than 22% after <a href="https://www.nasdaq.com/press-release/beautyhealth-reports-second-quarter-2024-financial-results-2024-08-08">posting its Q2 earnings report</a>.</li>



<li>Cutera (NASDAQ:<a href="https://investorplace.com/stock-quotes/cutr-stock-quote/">CUTR</a>) shares are dropping over 21% with its <a href="https://www.nasdaq.com/press-release/cuterar-announces-second-quarter-2024-financial-results-2024-08-08">latest earnings news</a>.</li>



<li>Microvast (NASDAQ:<a href="https://investorplace.com/stock-quotes/mvst-stock-quote/">MVST</a>) stock is falling more than 19% after releasing its <a href="https://ir.microvast.com/static-files/b376f438-a4e5-4a1a-ac22-a6107e450b24">Q2 2024 earnings</a>.</li>



<li>FiscalNote (NYSE:<a href="https://investorplace.com/stock-quotes/note-stock-quote/">NOTE</a>) shares are slipping over 18% after <a href="https://finance.yahoo.com/news/fiscalnote-holdings-inc-note-reports-231505554.html">posting a Q2 loss</a>.</li>



<li>Nerdy (NYSE:<a href="https://investorplace.com/stock-quotes/nrdy-stock-quote/">NRDY</a>) stock is dipping more than 18% after <a href="https://www.nasdaq.com/press-release/nerdy-announces-second-quarter-2024-financial-results-2024-08-08">releasing its Q2 earnings report</a>.</li>



<li>Five9 (NASDAQ:<a href="https://investorplace.com/stock-quotes/fivn-stock-quote/">FIVN</a>) shares close out our pre-market stock movers down over 15% with its <a href="https://www.nasdaq.com/press-release/five9-surpasses-1-billion-annual-revenue-run-rate-2024-08-08">most recent earnings report</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-aug-9th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
American Vanguard&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/avd-stock-quote/">AVD</a>) stock is falling on Friday after the specialty chemicals company announced its earnings for the <a href="https://www.nasdaq.com/press-release/american-vanguard-reports-q2-2024-results-2024-08-08">second quarter of 2024</a>.



The bad news for AVD stockholders starts with the company&rsquo;s diluted earnings per share of -9 cents. That&rsquo;s nowhere close to the 12 cents per share Wall Street was expecting. It&rsquo;s also worse than the -4 cents per share reported in the same period of the year prior.



Adding to this is the company&rsquo;s revenue of $128.21 million in Q2. Yet again, that failed to reach analysts&rsquo; revenue estimate of $133.6 million. It&rsquo;s also down 3.5% year-over-year from $132.8 million.



Acting American Vanguard CEO Timothy Donnelly said the following about these results.




&ldquo;Our profitability was reduced largely due to non-recurring charges, including severance compensation for the former CEO and other one-time costs including various expenses in support of our business transformation activity. That said, the company does not find these results to be acceptable and is focused on changing direction with urgency&rdquo;




<h2>Outlook Cut Hits AVD Stock</h2>



American Vanguard also reduced its outlook alongside these lackluster results. This has it expecting 2024 revenue to come in between $565 million&nbsp;and&nbsp;$580 million.&nbsp;That would see it missing Wall Street&rsquo;s revenue estimate of $596.75 million for the year.



AVD stock is down 28.1% as of Friday morning.



Investors will want to keep reading for more of the most recent stock market stories!



We have all of the hottest stock market news traders need to know about on Friday! That includes everything happening with shares of AN2 Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/antx-stock-quote/">ANTX</a>) stock, Nauticus Robotics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) stock and Iteris&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/iti-stock-quote/">ITI</a>) stock today. You can catch up on all of these matters by checking out the links below!



<h2>More Stock Market News for Friday</h2>



<ul><li><a href="https://investorplace.com/2024/08/why-is-an2-therapeutics-antx-stock-down-35-today/">Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/why-is-nauticus-robotics-kitt-stock-up-40-today/">Why Is Nauticus Robotics (KITT) Stock Up 40% Today?</a></li>



<li><a href="https://investorplace.com/2024/08/why-is-iteris-iti-stock-up-64-today/">Why Is Iteris (ITI) Stock Up 64% Today?</a></li>
</ul>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/why-is-american-vanguard-avd-stock-down-28-today/">Why Is American Vanguard (AVD) Stock Down 28% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is American Vanguard (AVD) Stock Down 28% Today?

American Vanguard Corporation 2024 Q2 - Results - Earnings Call Presentation

American Vanguard Corporation (AVD) Q2 2024 Earnings Call Transcript

The 1-Minute Market Report August 10, 2024

American Vanguard (AVD) has provided an update. American Vanguard Corporation's board has approved a compensation plan for the four executives curr...

Comments

American Vanguard

Notizie

Ultime notizie per American Vanguard (NYSE:AVD) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO